MustGrow BiologicsMGROF -2.22%29 Return-on-Tangible-Equity is -477.82% as of Mar. 2026. GuruFocus rates MGROF with a GF Score™ of 29/100. The stock has 3 warning signs investors should review. Among 249 Agriculture companies, MustGrow Biologics ranks worse than 99.6% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. MustGrow Biologics's annualized net income for the quarter that ended in Mar. 2026 was $-3.86 Mil. MustGrow Biologics's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $0.81 Mil. Therefore, MustGrow Biologics's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was -477.82%.
The historical rank and industry rank for MustGrow Biologics's Return-on-Tangible-Equity or its related term are showing as below:
MGROF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -816.2 Med: -119.29 Max: -12.51
Current: -816.2
During the past 10 years, MustGrow Biologics's highest Return-on-Tangible-Equity was -12.51%. The lowest was -816.20%. And the median was -119.29%.
MGROF's Return-on-Tangible-Equity is ranked worse than 99.6% of 249
companies
in the Agriculture industry
Industry Median: 7.84
vs MGROF: -816.20
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
MustGrow Biologics Return-on-Tangible-Equity Related Terms
MustGrow Biologics Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for MustGrow Biologics's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MGROF vs CTVA, CF, MOS: Return-on-Tangible-Equity Comparison
For the Agricultural Inputs subindustry, MustGrow Biologics's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MustGrow Biologics Return-on-Tangible-Equity vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, MustGrow Biologics's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where MustGrow Biologics's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -477.82% mean?
MustGrow Biologics (MGROF) has a Return-on-Tangible-Equity of -477.82% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on MustGrow Biologics and its competitors. According to the industry distribution chart, MustGrow Biologics ranks #248 out of 249 companies in the Agriculture industry, placing it in the top 99.6%.
Is MustGrow Biologics' Return-on-Tangible-Equity too high?
MustGrow Biologics' current Return-on-Tangible-Equity is -477.82%. Based on the distribution chart, MustGrow Biologics ranks #248 out of 249 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, MustGrow Biologics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' Return-on-Tangible-Equity compare to CTVA and CF?
According to the Agriculture industry distribution chart, MustGrow Biologics ranks #248 out of 249 companies for Return-on-Tangible-Equity. This places MustGrow Biologics in the lower half of its industry. The industry median Return-on-Tangible-Equity is 7.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for an Agriculture company?
The median Return-on-Tangible-Equity among Agriculture companies is 7.84, based on 249 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on MustGrow Biologics and its competitors. For the Agriculture industry, the median Return-on-Tangible-Equity is 7.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MustGrow Biologics's current Return-on-Tangible-Equity is -477.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
MustGrow Biologics (MGROF) has a current Return-on-Tangible-Equity of -477.82%. The current Return-on-Tangible-Equity is -477.82%. MustGrow Biologics' overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For MustGrow Biologics (MGROF), the current Return-on-Tangible-Equity is -477.82% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
29GF Score
Get the complete analysis for MGROF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MGROF has been successfully added to your 
